Kolexia
Molin Yann Oncologie médicale
Molin Yann
Oncologie médicale
Clinique de la Sauvegarde
Lyon, France
53 Activités
199 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome épidermoïde Tumeurs des voies biliaires Métastase tumorale Adénocarcinome Cholangiocarcinome Carcinome épidermoïde de la tête et du cou Tumeurs du pancréas Carcinomes Tumeurs de la tête et du cou

Collaborateurs

Voir plus
Kenouchi Ouarda
Kenouchi Ouarda
Cabinet libéral, Sainte-Foy-lès-Lyon, France
Ardisson Philippe
Ardisson Philippe
Clinique de la Sauvegarde, Lyon, France
Derbel Miled Olfa
Derbel Miled Olfa
Selarl Oncologie Beal Derbel Bally, Lyon, France
Carrabin Nicolas
Carrabin Nicolas
Cabinet libéral, Sainte-Foy-lès-Lyon, France

Industries

Voir plus
Novartis
13 collaboration(s)
Dernière en 2023
Janssen
11 collaboration(s)
Dernière en 2023
MSD
9 collaboration(s)
Dernière en 2023
Merck-Serono
2 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
SAFIR 03: A ctDNA Screening Program in Patients With HR+, HER2- Metastatic Breast Cancer for Detection of High-risk Relapse Patients on Any CDK4/6 Inhibitor and a Randomised Phase II Study Comparing Alpelisib Combined With Fulvestrant to Ribociclib Combined With Fulvestrant, in Patients With Persistent Targetable PIK3CA Mutations
Essai Clinique (Unicancer)   20 novembre 2023
Daily practices in chemotherapy for advanced gastric or gastroesophageal junction adenocarcinoma: METESTOMAC French prospective cohort.
Cancer medicine   16 novembre 2022
AMEBICA: Randomised Phase II/III Study, Assessing the Safety and Efficacy of Modified Folfirinox Versus Gemcis in Locally Advanced, Unresectable and/or Metastatic Bile Duct Tumours
Essai Clinique (CHU Saint-Étienne)   23 février 2022
Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   18 octobre 2021
52P Modified FOLFIRINOX versus CISGEM as first-line chemotherapy for advanced biliary tract cancer: Results of AMEBICA PRODIGE 38 randomized phase II trial
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
PALLIA-10, a screening tool to identify patients needing palliative care referral in comprehensive cancer centers: A prospective multicentric study (PREPA-10).
Cancer medicine   04 mai 2019
PRODIGE 51 - GASTFOX: Phase III randomised trial evaluating FOLFOX with or without DOCETAXEL (TFOX) as 1st line chemotherapy for locally advanced or metastatic oesophago-gastric adenocarcinoma
Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8-12 September 2017, Madrid, Spain   01 septembre 2017
Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma.
Drug design, development and therapy   26 novembre 2015
O6-Methylguanine-DNA methyltransferase status in neuroendocrine tumours: prognostic relevance and association with response to alkylating agents.
British journal of cancer   13 janvier 2015
Pneumocystis jirovecii pneumonia under everolimus in two patients with metastatic pancreatic neuroendocrine tumors.
Investigational new drugs   14 août 2014